FrancophonIA/ELRC3.0 huggingface dataset:
English: 6.1 List of excipients microcrystalline cellulose pregelatinized starch sodium starch glycolate magnesium stearate butylated methacrylate copolymer crospovidone sodium hydrogen carbonate citric acid colloidal silicon dioxide ferric oxide mannitol aspartame (E951) flavour Tutti-Frutti
Maltese: 6.1 Lista ta' eċċipjenti microcrystalline cellulose pregelatinized starch sodium starch glycolate magnesium stearate butylated methacrylate copolymer crospovidone sodium hydrogen carbonate citric acid colloidal silicon dioxide ferric oxide mannitol aspartame (E951) Togħma ta' Tutti-Frutti
English: Headache Insomnia
Maltese: Uġigħ ta' ras Insomnja
English: Neoclarityn tablets contain lactose.
Maltese: Din il-mediċina fiha lactose.
English: Neoclarityn 0.5 mg/ml oral solution
Maltese: Neoclarityn 0.5 mg/ml soluzzjoni orali
English: Neoclarityn oral solution contains sorbitol
Maltese: Neoclarityn soluzzjoni orali fiha sorbitol
English: propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate, purified water
Maltese: sucralose E 955, hypromellose 2910, sodium citrate dihydrate, essenza naturali u artifiċjali (babbilgam), citric acid anhydrous, disodium edetate, ilma purifikat
English: 6.1 List of excipients sorbitol,
Maltese: 6.1 Lista ta' eċċipjenti sorbitol, propylene glycol,
English: Children 1 through 5 years of age: 2.5 ml (1.25 mg) Neoclarityn oral solution once a day.
Maltese: Tfal minn sena sa 5 snin : 2.5 ml (1.25 mg) Neoclarityn soluzzjoni orali darba kuljum.
English: Children 6 through 11 years of age: 5 ml (2.5 mg) Neoclarityn oral solution once a day.
Maltese: Tfal minn 6 snin sa 11-il sena: 5 ml (2.5 mg) Neoclarityn soluzzjoni orali darba kuljum.
English: Neoclarityn oral solution contains sorbitol.
Maltese: Neoclarityn soluzzjoni orali fiha sorbitol.
English: Neoclarityn 0.5 mg/ml oral solution desloratadine
Maltese: Neoclarityn 0.5 mg/ml soluzzjoni orali desloratadine
English: Tablet coating: film coat (containing lactose monohydrate, hypromellose, titanium dioxide, macrogol 400, indigotin (E132)), clear coat (containing hypromellose, macrogol 400), carnauba wax, white wax.
Maltese: Kisja tar-rita : (li fiha lactose monohydrate, hypromellose, titanium dioxide, macrogol 400, indigotin (E132)), kisja trasparenti (li fiha hypromellose, macrogol 400), carnauba wax, white wax.
English: Efficacy of Neoclarityn oral solution has not been investigated in separate paediatric trials.
Maltese: L-effikaċja tas-soluzzjoni orali Neoclarityn ma ġietx investigata fi provi pedjatriċi separati.
English: Use caution when taking Neoclarityn with alcohol.
Maltese: Oqgħod attent meta tieħu Neoclarityn mal-alkoħol.
English: Other medicines and Neoclarityn
Maltese: Mediċini oħra u Neoclarityn
English: BOX OF 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLETS
Maltese: KAXXA TA' 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 PILLOLA
English: Neoclarityn oral solution, is supplied in 30, 50, 60, 100, 120, 150, 225 and 300 ml size Type III amber glass bottles closed with a plastic child resistant (C/R) screw closure having a multi-ply polyethylenefaced liner.
Maltese: Neoclarityn soluzzjoni orali, jiġi fi fliexken tal-ħġieġ kulur l-ambra tat-Tip III ta' daqsijiet ta' 30, 50, 60, 100, 120, 150, 225 u 300 ml, magħluqin b'għatu tal-plastik b'kamin li ma jistax jinfetaħ mit-tfal (C/R) li fih inforra b'ħafna saffi b'faċċata tal-polyethylene.
English: Neoclarityn 5 mg tablet desloratadine
Maltese: Neoclarityn pillola 5 mg desloratadine
English: Each ml of oral solution contains 0.5 mg desloratadine.
Maltese: Kull ml ta' soluzzjoni orali fih 0.5 mg desloratadine.
English: Neoclarityn 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side.
Maltese: Neoclarityn 2.5 mg pillola li tinħall fil-ħalq hija ħamra ċara, ittikkjata, u tonda immarkata b'“K” fuq naħa.
English: EU/1/00/161/001 1 tablet EU/1/00/161/002 2 tablets EU/1/00/161/003 3 tablets EU/1/00/161/004 5 tablets EU/1/00/161/005 7 tablets EU/1/00/161/006 10 tablets EU/1/00/161/007 14 tablets EU/1/00/161/008 15 tablets EU/1/00/161/009 20 tablets EU/1/00/161/010 21 tablets EU/1/00/161/011 30 tablets EU/1/00/161/012 50 tablets EU/1/00/161/013 100 tablets
Maltese: EU/1/00/161/007 14-il pillola EU/1/00/161/008 15-il pillola EU/1/00/161/009 20 pillola EU/1/00/161/010 21 pillola EU/1/00/161/011 30 pillola EU/1/00/161/012 50 pillola EU/1/00/161/013 100 pillola
English: There is limited clinical trial efficacy experience with the use of desloratadine in adolescents12 through 17 years of age (see sections 4.8 and 5.1).
Maltese: Hemm esperjenza limitata dwar l-effikaċja minn provi kliniċi bl-użu ta' desloratadine f'adolexxenti minn 12 sa 17-il sena (ara sezzjonijiet 4.8 u 5.1).
English: This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Neoclarityn orodispersible tablet.
Maltese: Dan il-prodott fih 1.4 mg phenylalanine għal kull doża ta' 2.5 mg ta' pillola li tinħall fil-ħalq Neoclarityn.
English: Neoclarityn tablets effectively controlled symptoms for 24 hours.
Maltese: Ilpilloli Neoclarityn ikkontrollaw is-sintomi b'mod effettiv għal 24 siegħa.
English: Packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 tablets.
Maltese: Pakketti ta' 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 90, 100 pillola.
English: Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria) Asthenia
Maltese: Reazzjonijiet ta' sensittività eċċessiva (bħal reazzjonijiet anafilattiċi, anġjoedema, ħakk, raxx u urtikarja) Astenja
English: Neoclarityn given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Maltese: Neoclarityn mogħti bħala doża waħda kuljum ta' 7.5 mg ma affettwax ilprestazzjonijiet psikomotorei fi provi kliniċi.
English: Neoclarityn 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets.
Maltese: Neoclarityn pilloli ta' 5 mg miksija b'rita huma ppakkjati f'folji f'pakketti ta' 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 jew 100 pillola.
English: 5 orodispersible tablets 6 orodispersible tablets 10 orodispersible tablets 12 orodispersible tablets 15 orodispersible tablets 18 orodispersible tablets 20 orodispersible tablets 30 orodispersible tablets 50 orodispersible tablets 60 orodispersible tablets 90 orodispersible tablets 100 orodispersible tablets
Maltese: 5 pilloli li jinħallu fil-ħalq 6 pilloli li jinħallu fil-ħalq 10 pilloli li jinħallu fil-ħalq 12-il pillola li jinħallu fil-ħalq 15-il pillola li jinħallu fil-ħalq 18-il pillola li jinħallu fil-ħalq 20 pillola li jinħallu fil-ħalq 30 pillola li jinħallu fil-ħalq 50 pillola li jinħallu fil-ħalq 60 pillola li jinħallu fil-ħalq 90 pillola li jinħallu fil-ħalq 100 pillola li jinħallu fil-ħalq
English: The most frequent of adverse events reported in excess of placebo were fatigue (1.2 %), dry mouth (0.8 %) and headache (0.6 %).
Maltese: L-aktar reazzjonijiet avversi frekwenti li kienu rrappurtati aktar minn dak tal-plaċebo kienu għeja (1.2%), ħalq xott (0.8%), u uġigħ ta' ras (0.6%).
English: At the recommended dose, Neoclarityn 5 mg orodispersible tablet was found to be bioequivalent to the Neoclarityn 5 mg conventional tablet formulation of desloratadine.
Maltese: Bid-doża rakkomandata, il-pillola Neoclarityn 5 mg li tinħall fil-ħalq instabet li hija bijoekwivalenti għall-formulazzjoni tal-pillola Neoclarityn 5 mg konvenzjonali ta' desloratadine.
English: Adults and adolescents 12 years of age and over The recommended dose is 10 ml (two 5 ml spoonfuls) of oral solution once a day.
Maltese: Adulti u adolexxenti minn 12-il sena 'l fuq Id-doża rakkomandata hija 10 ml (żewġ kuċċarini ta' 5 ml) tas-soluzzjoni orali darba kuljum.
English: Neoclarityn is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Maltese: Neoclarityn huwa indikat fl-adulti, fl-adolexxenti minn 12-il sena 'l fuq u tfal ta' bejn 6 u 11-il sena biex jittaffew is-sintomi assoċjati ma': - rinite allerġika (ara sezzjoni 5.1) - urtikarja (ara sezzjoni 5.1)
English: Neoclarityn orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet.
Maltese: Neoclarityn pillola li tinħall fil-ħalq hi ppakkjata f'folji b'doża waħda f'pakketti ta' 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 u 100 doża ta' pilloli li jinħallu fil-ħalq.
English: Neoclarityn effectively controlled symptoms for 24 hours.
Maltese: Neoclarityn ikkontrolla s-sintomi b'mod effettiv għal 24 siegħa.
English: MSD SHARP & DOHME GMBH Tel: 0800 673 673 673 (+49 (0) 89 4561 2612) e-mail@msd.de
Maltese: MSD SHARP & DOHME GMBH Tel: 0800 673 673 673
English: Neoclarityn oral solution is available in bottles of 30, 50, 60, 100, 120, 150, 225 and 300 ml, with a childproof cap. For all packages except the 150 ml bottle, a measuring spoon is provided, marked for doses of 2.5 ml and 5 ml.
Maltese: Neoclarityn soluzzjoni orali , jiġi fi fliexken ta' daqsijiet ta' 30, 50, 60, 100, 120, 150, 225 u 300 ml magħluqin b'għatu tal-plastik mhux faċli biex jiftħuh it-tfal.
English: Neoclarityn oral solution is an antiallergy medicine that does not make you drowsy.
Maltese: Neoclarityn soluzzjoni orali hija mediċina kontra l-allerġiji li ma traqqdekx.
English: Neoclarityn 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side.
Maltese: Neoclarityn 5 mg pillola li tinħall fil-ħalq hija ħamra ċara, ittikkjata, u tonda immarkata b'“A” fuq naħa.
English: The efficacy of Neoclarityn tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age.
Maltese: L-effikaċja tal-pilloli Neoclarityn ma ntwerietx b'mod ċar fi provi b'pazjenti adolexxenti minn 12 sa 17-il sena.
English: When given at the recommended doses, the plasma concentrations of desloratadine (see section 5.2) were comparable in the paediatric and adult populations.
Maltese: Meta ngħata biddożi rakkomandati, il-konċentrazzjonijiet ta' desloratadine fil-plażma (ara sezzjoni 5.2) kienu komparabbli fil-popolazzjonijiet pedjatriċi ma' dawk adulti.
English: EU/1/00/161/035 5 orodispersible tablets EU/1/00/161/036 6 orodispersible tablets EU/1/00/161/037 10 orodispersible tablets EU/1/00/161/038 12 orodispersible tablets EU/1/00/161/039 15 orodispersible tablets EU/1/00/161/040 18 orodispersible tablets EU/1/00/161/041 20 orodispersible tablets EU/1/00/161/042 30 orodispersible tablets EU/1/00/161/043 50 orodispersible tablets EU/1/00/161/044 60 orodispersible tablets EU/1/00/161/045 90 orodispersible tablets EU/1/00/161/046 100 orodispersible tablets
Maltese: EU/1/00/161/035 5 pilloli li jinħallu fil-ħalq EU/1/00/161/036 6 pilloli li jinħallu fil-ħalq EU/1/00/161/037 10 pilloli li jinħallu fil-ħalq EU/1/00/161/038 12-il pillola li jinħallu fil-ħalq EU/1/00/161/039 15-il pillola li jinħallu fil-ħalq EU/1/00/161/040 18-il pillola li jinħallu fil-ħalq EU/1/00/161/041 20 pillola li jinħallu fil-ħalq EU/1/00/161/042 30 pillola li jinħallu fil-ħalq EU/1/00/161/043 50 pillola li jinħallu fil-ħalq EU/1/00/161/044 60 pillola li jinħallu fil-ħalq EU/1/00/161/045 90 pillola li jinħallu fil-ħalq EU/1/00/161/046 100 pillola li jinħallu fil-ħalq
English: In the case of severe renal insufficiency, Neoclarityn should be used with caution (see section 5.2).
Maltese: F'każ ta' insuffiċjenza renali severa, Neoclarityn għandu jintuża b'attenzjoni (ara sezzjoni 5.2).
English: Neoclarityn orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding.
Maltese: Neoclarityn pillola li tinħall fil-ħalq hija mediċina kontra l-allerġiji li ma traqqdekx.
English: Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu.
Maltese: Informazzjoni dettaljata dwar din il-mediċina tinsab fuq is-sit elettroniku tal-Aġenzija Ewropea għallMediċini http://www.ema.europa.eu/.
English: In a clinical pharmacology trial, Neoclarityn tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1).
Maltese: Fi prova farmakoloġika klinika, pilloli Neoclarityn li ttieħdu flimkien mal-alkoħol ma żidux l-effetti tal-alkoħol li jxekkel il-prestazzjoni (ara sezzjoni 5.1).
English: Neoclarityn is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Maltese: Neoclarityn huwa indikat fl-adulti u fl-adolexxenti minn 12-il sena 'l fuq biex jittaffew is-sintomi assoċjati ma': - rinite allerġika (ara sezzjoni 5.1) - urtikarja (ara sezzjoni 5.1)
English: In clinical studies with Neoclarityn, the following side effects were reported as:
Maltese: Fi studji kliniċi b'Neoclarityn, l-effetti sekondarji li ġejjin kienu rrappurtati bħala:
English: In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets, the formulations were bioequivalent.
Maltese: Fi studji crossover b'doża waħda ta' pilloli Neoclarityn 5 mg li jinħallu fil-ħalq ma' pilloli Neoclarityn 5 mg konvenzjonali , il-formulazzjonijiet kienu bijoekwivalenti.
English: EU/1/00/161/047 5 orodispersible tablets EU/1/00/161/048 6 orodispersible tablets EU/1/00/161/049 10 orodispersible tablets EU/1/00/161/050 12 orodispersible tablets EU/1/00/161/051 15 orodispersible tablets EU/1/00/161/052 18 orodispersible tablets EU/1/00/161/053 20 orodispersible tablets EU/1/00/161/054 30 orodispersible tablets EU/1/00/161/055 50 orodispersible tablets EU/1/00/161/056 60 orodispersible tablets EU/1/00/161/057 90 orodispersible tablets EU/1/00/161/058 100 orodispersible tablets
Maltese: EU/1/00/161/047 5 pilloli li jinħallu fil-ħalq EU/1/00/161/048 6 pilloli li jinħallu fil-ħalq EU/1/00/161/049 10 pilloli li jinħallu fil-ħalq EU/1/00/161/050 12-il pillola li jinħallu fil-ħalq EU/1/00/161/051 15-il pillola li jinħallu fil-ħalq EU/1/00/161/052 18-il pillola li jinħallu fil-ħalq EU/1/00/161/053 20 pillola li jinħallu fil-ħalq EU/1/00/161/054 30 pillola li jinħallu fil-ħalq EU/1/00/161/055 50 pillola li jinħallu fil-ħalq EU/1/00/161/056 60 pillola li jinħallu fil-ħalq EU/1/00/161/057 90 pillola li jinħallu fil-ħalq EU/1/00/161/058 100 pillola li jinħallu fil-ħalq
English: BOX OF 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 ORODISPERSIBLE TABLETS
Maltese: KAXXA TA' 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 PILLOLA LI JINĦALLU FIL-ĦALQ
English: Neoclarityn tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials.
Maltese: Il-pilloli Neoclarityn mogħtija bħala doża waħda kuljum ta' 7.5 mg lill-adulti u adolexxenti ma affettwawx il-prestazzjonijiet psikomotorei fi provi kliniċi.
English: Neoclarityn is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Maltese: Neoclarityn huwa indikat fl-adulti, fl-adolexxenti u fi tfal ta' aktar minn sena biex jittaffew is-sintomi assoċjati ma': - rinite allerġika (ara sezzjoni 5.1) - urtikarja (ara sezzjoni 5.1)
English: 1 film-coated tablet 2 film-coated tablets 3 film-coated tablets 5 film-coated tablets 7 film-coated tablets 10 film-coated tablets 14 film-coated tablets 15 film-coated tablets 20 film-coated tablets 21 film-coated tablets 30 film-coated tablets 50 film-coated tablets 100 film-coated tablets
Maltese: Pillola 1 miksija b'rita 2 pilloli miksijin b'rita 3 pilloli miksijin b'rita 5 pilloli miksijin b'rita 7 pilloli miksijin b'rita 10 pilloli miksijin b'rita 14-il pillola miksija b'rita 15-il pillola miksija b'rita 20 pillola miksija b'rita 21 pillola miksija b'rita 30 pillola miksija b'rita 50 pillola miksija b'rita 100 pillola miksija b'rita
English: Neoclarityn 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Neoclarityn orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.
Maltese: Il-pilloli Neoclarityn 2.5 mg ma ġewx evalwati f'pazjenti pedjatriċi, madankollu b'relazzjoni mal-istudji dwar is-sejbiet tad-doża fit-tfal, iddejta farmakokinetika għall-pilloli li jinħallu fil-ħalq Neoclarityn tiffavorixxi l-użu tad-doża ta' 2.5 mg f'pazjenti pedjatriċi bejn 6 u 11-il sena.
English: What Neoclarityn is Neoclarityn contains desloratadine which is an antihistamine.
Maltese: Fi studji in vitro, desloratadine wera karatteristiċi kontra l-allerġiji.
English: Neoclarityn orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older.
Maltese: Neoclarityn itaffi s-sintomi assoċjati ma' rinite allerġika (infjammazzjoni tal-passaġġi fl-imnieħer ikkawżata minn allerġija, pereżempju hay fever jew allerġija għad-dust mites) fl-adulti u fl-adolexxenti minn 12-il sena 'l fuq.
English: As a precautionary measure, it is preferable to avoid the use of Neoclarityn during pregnancy.
Maltese: Bћala prekawzjoni hu preferribli li ma jintużax Neoclarityn waqt it-tqala.
English: This product contains 2.9 mg of phenylalanine per 5 mg dose of Neoclarityn orodispersible tablet.
Maltese: Dan il-prodott fih 2.9 mg ta' phenylalanine għal kull doża ta' 5 mg ta' pillola li tinħall fil-ħalq Neoclarityn.
English: oral solution
Maltese: Soluzzjoni orali
English: How to take Neoclarityn oral solution
Maltese: X'fih Neoclarityn soluzzjoni orali
English: At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Neoclarityn were reported in 3 % of patients in excess of those treated with placebo.
Maltese: Fid-doża rakkomandata, fi provi kliniċi li saru f'adulti u adolexxenti f'medda ta' indikazzjonijiet fosthom rinite allerġika u urtikarja idjopatika kronika, l-effetti mhux mixtieqa ta' Neoclarityn kienu rrappurtati fi 3% tal-pazjenti aktar minn dawk ikkurati bi plaċebo.
English: During the marketing of Neoclarityn, the following side effects were reported as:
Maltese: Matul it-tqegħid fis-suq ta' Neoclarityn, l-effetti sekondarji li ġejjin ġew irrappurtati bħala:
English: The prevalence of this poor metaboliser phenotype was comparable for adult (6 %) and paediatric subjects 2- to 11-year old (6 %), and greater among Blacks (18 % adult, 16 % paediatric) than Caucasians (2 % adult, 3 % paediatric) in both populations however the safety profile of these subjects was not different from that of the general population.
Maltese: Il-prevalenza ta' dan il-fenotip ta' metabolizzatur dgħajjef kienet akbar f'adulti Suwed milli f'adulti Kawkasi (18% vs 2%), madankollu fiż-żewġ popolazzjonijiet, il-profil tas-sigurtà ta' dawn l-individwi ma kienx differenti minn dak tal-popolazzjoni ġenerali.
English: Neoclarityn 5 mg orodispersible tablets desloratadine
Maltese: Neoclarityn 5 mg pillola miksija b'rita desloratadine
English: Neoclarityn is an antiallergy medicine that does not make you drowsy.
Maltese: Neoclarityn hija mediċina kontra l-allerġiji li ma traqqdekx.
English: How to take Neoclarityn
Maltese: X'fih Neoclarityn
English: Adverse reactions seen with Neoclarityn
Maltese: Reazzjonijiet avversi li dehru b'Neoclarityn
English: ● rash
Maltese: ● sturdament
English: In adult and adolescent patients with allergic rhinitis, Neoclarityn tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Maltese: F'pazjenti adulti u adolexxenti b'rinite allerġika, il-pilloli Neoclarityn kienu effettivi biex iserrħu sintomi bħal għatis, tnixxija mill-imnieħer u ħakk, kif ukoll ħakk, dmugħ u ħmura fl-għajnejn, u ħakk fis-saqaf tal-ħalq.
English: Neoclarityn 2.5 mg orodispersible tablets desloratadine
Maltese: Neoclarityn 2.5 mg pilloli li jinħallu fil-ħalq desloratadine
English: Neoclarityn tablets were effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire.
Maltese: Neoclarityn kien effettiv biex iserraħ il-problemi relatati ma' rinite allerġika tal-istaġun kif jidher millpunteġġ totali tal-kwestjonarju fuq il-kwalità tal-ħajja b'rinokonġuntivite.
English: Non-clinical studies conducted with desloratadine and loratadine demonstrated that there are no qualitative or quantitative differences in the toxicity profile of desloratadine and loratadine at comparable levels of exposure to desloratadine.
Maltese: Studji li mhumiex kliniċi li saru b'desloratadine u loratadine urew li m'hemmx differenzi mill-lat kwalitattiv jew kwantitattiv fil-profil ta' tossiċità ta' desloratadine u loratadine f'livelli komparabbli ta' esponiment għal desloratadine.
English: In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neoclarityn tablets were reported in 3 % of patients in excess of those treated with placebo.
Maltese: Fi provi kliniċi ta' medda ta' indikazzjonijiet fosthom rinite allerġika u urtikarja idjopatika kronika, bid-doża rakkomandata ta' 5 mg kuljum, l-effetti mhux mixtieqa bil-pilloli Neoclarityn kienu rrappurtati fi 3% tal-pazjenti aktar minn dawk ikkurati bi plaċebo.
English: In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neoclarityn were reported in 3 % of patients in excess of those treated with placebo.
Maltese: Fi provi kliniċi ta' medda ta' indikazzjonijiet fosthom rinite allerġika u urtikarja idjopatika kronika, bid-doża rakkomandata ta' 5 mg kuljum, l-effetti mhux mixtieqa b'Neoclarityn kienu rrappurtati fi 3% tal-pazjenti aktar minn dawk ikkurati bi plaċebo.
English: Neoclarityn orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 6 years of age and older.
Maltese: Neoclarityn pillola li tinħall fil-ħalq itaffi s-sintomi assoċjati ma' rinite allerġika (infjammazzjoni talpassaġġi fl-imnieħer ikkawżata minn allerġija, pereżempju hay fever jew allerġija għad-dust mites) fladulti, fl-adolexxenti u fit-tfal minn 6 snin 'il fuq.
English: Tel: +386 1 5204 201 msd.slovenia@merck.com
Maltese: Tel: +421 2 58282010 dpoc_czechslovak@merck.com
English: Maximum desloratadine concentration was about 3-fold higher at approximately 7 hours with a terminal phase half-life of approximately 89 hours.
Maltese: Il-konċentrazzjoni massima ta' desloratadine kienet daqs 3 darbiet ogħla wara madwar 7 sigħat, bil-fażi terminali tal-halflife ta' madwar 89 siegħa.
English: The safety and efficacy of Neoclarityn 0.5 mg/ml oral solution in children below the age of 1 year have not been established.
Maltese: Is-sigurtà u l-effikaċja ta' Neoclarityn 0.5 mg/ml soluzzjoni orali fit-tfal ta' inqas minn sena ma ġewx determinati s'issa.
English: Do not take Neoclarityn oral solution - if you are allergic to desloratadine, or to any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Maltese: Tiħux Neoclarityn soluzzjoni orali - jekk inti allerġiku għal desloratadine jew għal xi sustanza oħra ta' din il-mediċina (imniżżla fis sezzjoni 6) jew għal loratadine.
English: For the 150 ml package, a measuring spoon or an oral measuring syringe is provided, marked for doses of 2.5 ml and 5 ml.
Maltese: Għall-pakkett ta' 150 ml, hemm kuċċarina tal-kejl jew siringa biex titkejjel doża mill-ħalq mmarkati għad-dożi tat-2.5 ml u 5 ml.
English: Neoclarityn orodispersible tablet contains aspartame This product contains aspartame.
Maltese: Neoclarityn pillola li tinħall fil-ħalq fih aspartame Dan il-prodott fih aspartame.